For: | Abbas Z, Afzal R. Life cycle and pathogenesis of hepatitis D virus: A review. World J Hepatol 2013; 5(12): 666-675 [PMID: 24409335 DOI: 10.4254/wjh.v5.i12.666] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v5/i12/666.htm |
Number | Citing Articles |
1 |
Laura Iulia Grecu, Mariana Pavel-Tanasa, Lilia Matei, Camelia Sultana, Simona Maria Ruta, Razvan Ioan Grecu, Ramona Gabriela Ursu, Petru Cianga, Luminita Smaranda Iancu. Molecular Epidemiology of Hepatitis D Virus in the North-East Region of Romania. Pathogens 2024; 13(9): 793 doi: 10.3390/pathogens13090793
|
2 |
Anne Monette, Andrew J. Mouland. Biology of T Cells - Part B. International Review of Cell and Molecular Biology 2019; 342: 175 doi: 10.1016/bs.ircmb.2018.07.006
|
3 |
F. Fatehi Chenar, Y.N. Kyrychko, K.B. Blyuss. Mathematical model of immune response to hepatitis B. Journal of Theoretical Biology 2018; 447: 98 doi: 10.1016/j.jtbi.2018.03.025
|
4 |
Aiman Ghufran. Gastrointestinal and Liver Disorders in Women’s Health. 2019; : 265 doi: 10.1007/978-3-030-25626-5_17
|
5 |
Castine Bernardy, James Malley. Impacts of Surface Characteristics and Dew Point on the Blue-Light (BL405) Inactivation of Viruses. Microorganisms 2023; 11(11): 2638 doi: 10.3390/microorganisms11112638
|
6 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Shirokova. Immune disorders and rheumatologic manifestations of viral hepatitis. World Journal of Gastroenterology 2021; 27(18): 2073-2089 doi: 10.3748/wjg.v27.i18.2073
|
7 |
Megan M. Xue, Jeffrey S. Glenn, Daniel H. Leung. Hepatitis D in Children. Journal of Pediatric Gastroenterology and Nutrition 2015; 61(3): 271 doi: 10.1097/MPG.0000000000000859
|
8 |
Nehna Abdul Majeed, Asif A. Hitawala, Theo Heller, Christopher Koh. Diagnosis of HDV: From virology to non‐invasive markers of fibrosis. Liver International 2023; 43(S1): 31 doi: 10.1111/liv.15515
|
9 |
Rodrigo A. Villanueva, Alejandra Loyola. Pre- and Post-Transcriptional Control of HBV Gene Expression: The Road Traveled towards the New Paradigm of HBx, Its Isoforms, and Their Diverse Functions. Biomedicines 2023; 11(6): 1674 doi: 10.3390/biomedicines11061674
|
10 |
Megan S. McAfee, Trung P. Huynh, John L. Johnson, Bertram L. Jacobs, Joseph N. Blattman. Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity. Virology 2015; 484: 153 doi: 10.1016/j.virol.2015.05.021
|
11 |
Keisha R. Barton, Daniel H. Leung. Viral Hepatitis in Children. 2019; : 169 doi: 10.1007/978-981-13-0050-9_13
|
12 |
Haris Muhammad, Aniqa Tehreem, Muhammad Baraa Hammami, Peng-Sheng Ting, Ramzan Idilman, Ahmet Gurakar. Hepatitis D virus and liver transplantation: Indications and outcomes. World Journal of Hepatology 2021; 13(3): 291-299 doi: 10.4254/wjh.v13.i3.291
|
13 |
Taravt Bamdad, Atefeh Yari. Encyclopedia of Infection and Immunity. 2022; : 113 doi: 10.1016/B978-0-12-818731-9.00078-1
|
14 |
S. F. Galimova. Chronic hepatitis D. Dokazatel'naya gastroenterologiya 2015; 4(4): 32 doi: 10.17116/dokgastro201543-432-42
|
15 |
|
16 |
Ibrahim Halil Bahcecioglu, Abdurrahman Sahin. Treatment of Delta Hepatitis: Today and in the Future - A review. Infectious Diseases 2017; 49(4): 241 doi: 10.1080/23744235.2016.1271998
|
17 |
Melissa Montoya-Guzmán, Carolina Posada-Álvarez, Laura Camila Lopera-Restrepo, Diana di Filippo-Villa, María-Cristina Navas. Infección por el virus de la hepatitis delta. Hepatología 2020; : 116 doi: 10.52784/27112330.120
|
18 |
Abdulmajeed A. Albarrak, Ky-Dieu Tran, Veysel Tahan. Viral Hepatitis: Chronic Hepatitis B. 2018; : 95 doi: 10.1007/978-3-319-93449-5_8
|
19 |
Kathryn Olsen, Sara Mahgoub, Sarah Al-Shakhshir, Akram Algieder, Sowsan Atabani, Ayman Bannaga, Ahmed M Elsharkawy. Recent treatment advances and practical management of hepatitis D virus. Clinical Medicine 2023; 23(4): 403 doi: 10.7861/clinmed.2022-0556
|
20 |
Yang Yang, Marie-Laure Fogeron, Alexander A. Malär, Lauriane Lecoq, Alexander B. Barnes, Beat H. Meier, Anja Böckmann, Morgane Callon. Hepatitis Delta Antigen Retains the Assembly Domain as the Only Rigid Entity. Journal of the American Chemical Society 2024; 146(43): 29531 doi: 10.1021/jacs.4c09409
|
21 |
Nikhil Sharma, Sunit K. Singh. Implications of non‐coding RNAs in viral infections. Reviews in Medical Virology 2016; 26(5): 356 doi: 10.1002/rmv.1893
|
22 |
Denitsa Tsaneva-Damyanova, Zhivka Stoykova, Irina Ivanova, Tsvetelina Kostadinova, Liliya Ivanova. Hepatitis D virus in Bulgaria: virology, epidemiology and pathogenesis in chronic HBV carriers with liver dysfunction. Scripta Scientifica Medica 2020; 52(3): 12 doi: 10.14748/ssm.v52i3.6610
|
23 |
Joy Void-Holmes, Deborah Cartee. Infection Control in the Dental Office in the Era of COVID-19. 2024; : 27 doi: 10.1007/978-3-031-64611-9_3
|
24 |
Zaigham Abbas, Minaam Abbas. Management of hepatitis delta: Need for novel therapeutic options. World Journal of Gastroenterology 2015; 21(32): 9461-9465 doi: 10.3748/wjg.v21.i32.9461
|
25 |
Diana Asema Asandem, Selorm Philip Segbefia, Kwadwo Asamoah Kusi, Joseph Humphrey Kofi Bonney. Hepatitis B Virus Infection: A Mini Review. Viruses 2024; 16(5): 724 doi: 10.3390/v16050724
|
26 |
Zaigham Abbas, Syed Salman Ali, Lubna Shazi. Interferon alpha versus any other drug for chronic hepatitis D. Cochrane Database of Systematic Reviews 2015; doi: 10.1002/14651858.CD011727
|
27 |
|
28 |
Xin Ye, Chise Tateno, Emily P. Thi, Masakazu Kakuni, Nicholas M. Snead, Yuji Ishida, Trisha R. Barnard, Michael J. Sofia, Takashi Shimada, Amy C. H. Lee. Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model. ACS Infectious Diseases 2019; 5(5): 738 doi: 10.1021/acsinfecdis.8b00192
|
29 |
Alexander M. Sy, Christopher B. O’Brien. Liver Failure. 2020; : 167 doi: 10.1007/978-3-030-50983-5_9
|
30 |
Erika Lasda, Roy Parker. Circular RNAs: diversity of form and function. RNA 2014; 20(12): 1829 doi: 10.1261/rna.047126.114
|
31 |
Brian Pearlman. Hepatitis Delta Infection: A Clinical Review. Seminars in Liver Disease 2023; 43(03): 293 doi: 10.1055/a-2133-8614
|
32 |
Ben L Da, Theo Heller, Christopher Koh. Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterology Report 2019; 7(4): 231 doi: 10.1093/gastro/goz023
|
33 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2
|
34 |
Mianzhi Chen, Dan Du, Wen Zheng, Mingheng Liao, Lu Zhang, Ge Liang, Meng Gong. Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathioneS-transferase P1 and induces liver injury and hepatocarcinogenesis. Biochemistry and Cell Biology 2019; 97(2): 130 doi: 10.1139/bcb-2017-0321
|
35 |
Nathalie Mentha, Sophie Clément, Francesco Negro, Dulce Alfaiate. A review on hepatitis D: From virology to new therapies. Journal of Advanced Research 2019; 17: 3 doi: 10.1016/j.jare.2019.03.009
|
36 |
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I. Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu. Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Journal of the Formosan Medical Association 2021; 120(1): 303 doi: 10.1016/j.jfma.2020.10.002
|
37 |
Johanna Landahl, Jan Hendrik Bockmann, Christoph Scheurich, Christin Ackermann, Verena Matzat, Janna Heide, Tungalag Nuurei, Gianluca D’Antonio, Johann von Felden, Alessandro Sette, Sven Peine, Ansgar W Lohse, Marc Luetgehetmann, Matthias Marget, John Sidney, Julian Schulze zur Wiesch. Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II–Restricted, Hepatitis Delta Virus (HDV)–Specific T-Cell Responses Regardless of Clinical Status. The Journal of Infectious Diseases 2019; 219(4): 568 doi: 10.1093/infdis/jiy549
|
38 |
Poonam Mathur, Arshi Khanam, Shyam Kottilil. Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative Review. Microorganisms 2024; 12(11): 2177 doi: 10.3390/microorganisms12112177
|
39 |
|
40 |
Olympia E. Anastasiou, Heiner Wedemeyer. Liver Immunology. 2020; : 287 doi: 10.1007/978-3-030-51709-0_18
|
41 |
Matthew August Odenwald, Sonali Paul. Viral hepatitis: Past, present, and future. World Journal of Gastroenterology 2022; 28(14): 1405-1429 doi: 10.3748/wjg.v28.i14.1405
|
42 |
Kuihao Chen, Zhe Gao. Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects. Molecules 2024; 29(20): 4872 doi: 10.3390/molecules29204872
|
43 |
Zhimin Guo, Thomas King. Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection. International Journal of Molecular Sciences 2015; 16(8): 19537 doi: 10.3390/ijms160819537
|
44 |
Luna Colagrossi, Romina Salpini, Rossana Scutari, Luca Carioti, Arianna Battisti, Lorenzo Piermatteo, Ada Bertoli, Lavinia Fabeni, Carmine Minichini, Pascale Trimoulet, Hervé Fleury, Elena Nebuloso, Maria De Cristofaro, Giuseppina Cappiello, Alberto Spanò, Vincenzo Malagnino, Terenzio Mari, Angelo Barlattani, Nerio Iapadre, Miriam Lichtner, Claudio Mastroianni, Ilaria Lenci, Caterina Pasquazzi, Giuseppe De Sanctis, Alfonso Galeota Lanza, Maria Stanzione, Gianfranca Stornaiuolo, Massimo Marignani, Loredana Sarmati, Massimo Andreoni, Mario Angelico, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Nicola Coppola, Valentina Svicher. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets. Viruses 2018; 10(7): 363 doi: 10.3390/v10070363
|
45 |
E. Shirvani-Dastgerdi, S. Amini-Bavil-Olyaee, S. Moayed Alavian, C. Trautwein, F. Tacke. Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression. Clinical Microbiology and Infection 2015; 21(5): 510.e11 doi: 10.1016/j.cmi.2014.12.008
|
46 |
Bhavana Tetali, Brianna Kuperus, Nikhilesh Mazumder. Identifying and Screening At-Risk Patients for Hepatitis Delta Virus: A Case Report. Cureus 2023; doi: 10.7759/cureus.33660
|
47 |
Christopher Koh, Theo Heller, Jeffrey S. Glenn. Pathogenesis of and New Therapies for Hepatitis D. Gastroenterology 2019; 156(2): 461 doi: 10.1053/j.gastro.2018.09.058
|
48 |
Yukihiro Nakanishi, Romil Saxena. Essentials of Anatomic Pathology. 2016; : 1969 doi: 10.1007/978-3-319-23380-2_44
|
49 |
|
50 |
Shibin Qu, Xisheng Yang, Xiaolei Li, Jianlin Wang, Yuan Gao, Runze Shang, Wei Sun, Kefeng Dou, Haimin Li. Circular RNA: A new star of noncoding RNAs. Cancer Letters 2015; 365(2): 141 doi: 10.1016/j.canlet.2015.06.003
|
51 |
I. P. Balmasova, R. I. Sepiashvili, T. A. Slavyanskaya, E. S. Malova, Ya. R. Sepiashvili. COINFECTION BY HEPATITIS B AND HEPATITIS DELTA VIRUSES: MOLECULAR BIOLOGY OF PATHOGENS AND PROSPECTS OF PHARMACOTHERAPY. Journal of microbiology, epidemiology and immunobiology 2018; 95(2): 95 doi: 10.36233/0372-9311-2018-2-95-102
|
52 |
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli, Mariantonietta Pisaturo. HDV infection in immigrant populations. Journal of Medical Virology 2019; 91(12): 2049 doi: 10.1002/jmv.25570
|
53 |
Luciana Costa Faria, Débora Raquel Benedita Terrabuio, Hakan Leblebicioglu, Shirish Huprikar. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018; 102(2S): S66 doi: 10.1097/TP.0000000000002013
|
54 |
Yeshambel Belyhun, Uwe Gerd Liebert, Melanie Maier. Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0844-z
|
55 |
Castine Bernardy, James Malley. Virus Behavior after UV254 Treatment of Materials with Different Surface Properties. Microorganisms 2023; 11(9): 2157 doi: 10.3390/microorganisms11092157
|
56 |
Lennart Hermanussen, Sibylle Lampalzer, Jan-Hendrik Bockmann, Annerose E. Ziegler, Felix Piecha, Maura Dandri, Sven Pischke, Friedrich Haag, Ansgar W. Lohse, Marc Lütgehetmann, Christina Weiler-Normann, Julian Schulze zur Wiesch. Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1169096
|
57 |
Emuejevuoke Umukoro, Joseph J. Alukal, Kevin Pak, Julio Gutierrez. State of the Art. Clinics in Liver Disease 2023; 27(4): 937 doi: 10.1016/j.cld.2023.05.008
|
58 |
Minaam Abbas, Zaigham Abbas. Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D. World Journal of Hepatology 2017; 9(22): 967-972 doi: 10.4254/wjh.v9.i22.967
|